Registration number:
Cornwall Medical Group Ltd
for the Year Ended 31 March 2026
Cornwall Medical Group Ltd
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Cornwall Medical Group Ltd
Company Information
|
Directors |
Dr G Lin Sin Cho Dr R Murthy Dr K Smithson Dr G E Moon Mr J S Casey |
|
Registered office |
|
Cornwall Medical Group Ltd
(Registration number: 13540921)
Balance Sheet as at 31 March 2026
|
Note |
2026 |
2025 |
|
|
Fixed assets |
|||
|
Tangible assets |
|
|
|
|
Current assets |
|||
|
Stocks |
|
|
|
|
Debtors |
|
|
|
|
Cash at bank and in hand |
|
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net current liabilities |
( |
( |
|
|
Total assets less current liabilities |
( |
( |
|
|
Provisions for liabilities |
( |
( |
|
|
Net liabilities |
( |
( |
|
|
Capital and reserves |
|||
|
Called up share capital |
|
|
|
|
Retained earnings |
( |
( |
|
|
Shareholders' deficit |
( |
( |
Cornwall Medical Group Ltd
(Registration number: 13540921)
Balance Sheet as at 31 March 2026
For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
|
......................................... |
Cornwall Medical Group Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026
|
General information |
The company is a private company limited by share capital, incorporated in England.
The address of its registered office is:
These financial statements were authorised for issue by the
|
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Cornwall Medical Group Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026
Going concern
The directors acknowledge the company's result for the year and the balance sheet position - which reflects that the company has both net current liabilities and net liabilities at the year end date.
Included within creditors: amounts due within one year is £170,006 (2025: £163,805) owed to the parent company: Probus Surgery Limited. This was loaned to the company to support start up costs and to support ongoing trading, needed due to the infantile stage of this company. The parent company has provided assurance that this debt will not be called until the company is in a position to afford the repayment.
On the basis of these assurances, the directors have satisfied themselves that the company is a going concern and have prepared the accounts on this basis.
Revenue recognition
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.
Tax
Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Cornwall Medical Group Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
|
Asset class |
Depreciation method and rate |
|
Furniture, fittings and equipment |
33% reducing balance |
Stocks
Stocks are stated at the lower of cost and estimated selling price.
At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
Cornwall Medical Group Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026
|
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
Cornwall Medical Group Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026
|
Tangible assets |
|
Furniture, fittings and equipment |
Total |
|
|
Cost or valuation |
||
|
At 1 April 2025 |
|
|
|
At 31 March 2026 |
|
|
|
Depreciation |
||
|
At 1 April 2025 |
|
|
|
Charge for the year |
|
|
|
At 31 March 2026 |
|
|
|
Carrying amount |
||
|
At 31 March 2026 |
|
|
|
At 31 March 2025 |
|
|
|
Stocks |
|
2026 |
2025 |
|
|
Other inventories |
|
|
|
Debtors |
|
Current |
2026 |
2025 |
|
Amounts owed by related parties |
|
- |
|
Prepayments |
|
|
|
Other debtors |
|
|
|
|
|
Cornwall Medical Group Ltd
Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026
|
Creditors |
Creditors: amounts falling due within one year
|
Note |
2026 |
2025 |
|
|
Due within one year |
|||
|
Trade creditors |
|
- |
|
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
|
|
|
|
Accruals and deferred income |
|
|
|
|
Other creditors |
|
|
|
|
|
|
|
Share capital |
Allotted, called up and fully paid shares
|
2026 |
2025 |
|||
|
No. |
£ |
No. |
£ |
|
|
|
|
100 |
|
100 |
|
Related party transactions |
The company's immediate parent company is Probus Surgery Limited, incorporated in England and Wales.
The company has taken advantage of the exemption under FRS 102 from the disclosure of related party transactions with entities that are wholly owned within the group.